Pharmaceuticals

Dengvaxia Market Insights Highlighting Opportunities Supporting Growth To 2030

May 5, 2026May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Dengvaxia Market During 2026–2030?

The market for dengvaxia has experienced rapid expansion in recent years. Its valuation is set to rise from $213.36 million in 2025 to $250.81 million in 2026, achieving a compound annual growth rate (CAGR) of 17.6%. This historical growth can be linked to factors like recurring dengue outbreaks, a substantial disease burden in tropical climates, governmental immunization efforts, restricted treatment avenues for dengue, and heightened public health consciousness.

The market for dengvaxia is anticipated to experience significant expansion over the coming years. This market is projected to reach $473.95 million by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. Factors contributing to this growth during the projection period include broader vaccination coverage, the growing spread of mosquitoes due to climate change, increased financial support for public health, enhanced infrastructure for vaccine distribution, and a surge in demand for travel-related immunizations. Key trends anticipated for the forecast timeframe encompass the wider implementation of dengue vaccination initiatives, a heightened emphasis on preventing endemic diseases, an increase in public health immunization campaigns, more rigorous monitoring of mosquito-borne illnesses, and reinforced vaccination efforts for children and adolescents.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20035&type=smp

Which Factors Are Influencing The Growth Of The Dengvaxia Market?

The dengvaxia market is anticipated to expand due to the significant occurrence of dengue. This viral ailment, spread by Aedes mosquitoes, manifests with flu-like symptoms, intense pain, and can progress to severe, life-threatening conditions like dengue hemorrhagic fever or dengue shock syndrome. The growing spread of dengue can be attributed to factors such as climate shifts, increased urbanization, more travel, and larger mosquito breeding sites, which together lead to higher infection rates and a greater need for both prevention and treatment. Dengvaxia offers protection against dengue by acting as an effective vaccine that prompts the immune system to mount a defensive reaction against the virus, thereby lowering the chances of infection and severe health issues, and enhancing public health in regions where the disease is common. For example, in June 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, indicated that the Americas recorded more than 9.7 million dengue cases, which is twice the 4.6 million cases reported in 2023. Puerto Rico announced a public health emergency due to 1,498 cases, and 745 cases were documented among U.S. travelers. Consequently, the elevated incidence of dengue is propelling the growth within the dengvaxia market.

Dengvaxia Market Driver: Impact Of Rising International Travel On Market Growth

The dengvaxia market is projected to expand with the increase in international travel. International travel involves journeys undertaken between different nations for activities such as tourism, business, or educational pursuits. A surge in global mobility heightens the potential for infectious diseases, including dengue, to spread, thereby stimulating the need for preventative solutions like vaccines. Dengvaxia serves a crucial role amidst increasing international travel by safeguarding individuals journeying to regions where dengue is prevalent and by minimizing the inter-country transmission of the disease. For instance, in May 2024, data from the Office for National Statistics, a UK-based government department, revealed that international visits to the UK significantly climbed from 31.2 million in 2022 to 38.0 million in 2023. Consequently, the uptick in international travel will contribute to the growth of the dengvaxia market.

How Is The Dengvaxia Market Segmented Across Different Segment Categories?

The dengvaxia market covered in this report is segmented –

1) By Type: Dengvaxia, Other Types

2) By Distribution Channel: Hospitals, Clinics, Public Health Programs

3) By Clinical Indication: Prevention In Previously Infected Individuals, Protection In High-Risk Regions, Traveler Immunization, Pediatric And Adolescent Use

Which Organizations Play A Role In The Dengvaxia Market Landscape?

Major companies operating in the dengvaxia market are Sanofi Pasteur Inc.

Get The Full Dengvaxia Market Report:

https://www.thebusinessresearchcompany.com/report/dengvaxia-global-market-report

Where Is The Dengvaxia Market Most Concentrated Geographically?

Asia-Pacific was the largest region in the dengvaxia market in 2025. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengvaxia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Dengvaxia Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/dengvaxia-global-market-report

Browse Through More Reports Similar to the Global Dengvaxia Market 2026, By The Business Research Company

Rare Neurological Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Vaccine Contract Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccine-contract-manufacturing-global-market-report

Malaria Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/malaria-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795